nodes	percent_of_prediction	percent_of_DWPC	metapath
Thioridazine—CYP1A2—Imiquimod—skin cancer	0.126	0.161	CbGbCtD
Thioridazine—CYP2C8—Vismodegib—skin cancer	0.113	0.144	CbGbCtD
Thioridazine—CYP2C19—Vismodegib—skin cancer	0.095	0.121	CbGbCtD
Thioridazine—CYP2E1—Dacarbazine—skin cancer	0.0918	0.117	CbGbCtD
Thioridazine—CYP2C9—Vismodegib—skin cancer	0.079	0.101	CbGbCtD
Thioridazine—CYP1A2—Vemurafenib—skin cancer	0.0693	0.0883	CbGbCtD
Thioridazine—CYP2D6—Vemurafenib—skin cancer	0.0571	0.0728	CbGbCtD
Thioridazine—CYP1A2—Dacarbazine—skin cancer	0.0531	0.0677	CbGbCtD
Thioridazine—CYP2C8—Fluorouracil—skin cancer	0.0402	0.0513	CbGbCtD
Thioridazine—CYP1A2—Fluorouracil—skin cancer	0.0311	0.0397	CbGbCtD
Thioridazine—CYP2C9—Fluorouracil—skin cancer	0.0281	0.0358	CbGbCtD
Thioridazine—HRH1—nose—skin cancer	0.00613	0.108	CbGeAlD
Thioridazine—Amenorrhoea—Vismodegib—skin cancer	0.00529	0.0345	CcSEcCtD
Thioridazine—DRD1—nerve—skin cancer	0.00376	0.0662	CbGeAlD
Thioridazine—Hepatotoxicity—Vemurafenib—skin cancer	0.00372	0.0243	CcSEcCtD
Thioridazine—Parkinsonism—Fluorouracil—skin cancer	0.00297	0.0194	CcSEcCtD
Thioridazine—Sudden death—Fluorouracil—skin cancer	0.00264	0.0172	CcSEcCtD
Thioridazine—Eruption—Dactinomycin—skin cancer	0.00264	0.0172	CcSEcCtD
Thioridazine—HTR2A—hindlimb—skin cancer	0.00241	0.0424	CbGeAlD
Thioridazine—Photosensitivity—Vemurafenib—skin cancer	0.00237	0.0155	CcSEcCtD
Thioridazine—HTR7—nerve—skin cancer	0.00235	0.0414	CbGeAlD
Thioridazine—DRD2—nerve—skin cancer	0.00222	0.0391	CbGeAlD
Thioridazine—Hepatotoxicity—Dactinomycin—skin cancer	0.0021	0.0137	CcSEcCtD
Thioridazine—HTR2A—appendage—skin cancer	0.00207	0.0364	CbGeAlD
Thioridazine—HTR7—endothelium—skin cancer	0.002	0.0352	CbGeAlD
Thioridazine—Nasal congestion—Imiquimod—skin cancer	0.00195	0.0127	CcSEcCtD
Thioridazine—Extrapyramidal disorder—Temozolomide—skin cancer	0.00195	0.0127	CcSEcCtD
Thioridazine—Cholestasis—Temozolomide—skin cancer	0.00193	0.0126	CcSEcCtD
Thioridazine—Hepatotoxicity—Temozolomide—skin cancer	0.0019	0.0124	CcSEcCtD
Thioridazine—Dermatitis exfoliative—Imiquimod—skin cancer	0.00188	0.0123	CcSEcCtD
Thioridazine—HTR7—blood vessel—skin cancer	0.00185	0.0325	CbGeAlD
Thioridazine—Lethargy—Imiquimod—skin cancer	0.00181	0.0118	CcSEcCtD
Thioridazine—Eosinophilia—Vemurafenib—skin cancer	0.00178	0.0116	CcSEcCtD
Thioridazine—Systemic lupus erythematosus—Docetaxel—skin cancer	0.00176	0.0115	CcSEcCtD
Thioridazine—Menstruation irregular—Docetaxel—skin cancer	0.00176	0.0115	CcSEcCtD
Thioridazine—Amenorrhoea—Temozolomide—skin cancer	0.00167	0.0109	CcSEcCtD
Thioridazine—Photosensitivity reaction—Vemurafenib—skin cancer	0.00164	0.0107	CcSEcCtD
Thioridazine—Eruption—Docetaxel—skin cancer	0.00159	0.0103	CcSEcCtD
Thioridazine—Aplastic anaemia—Dactinomycin—skin cancer	0.00152	0.00994	CcSEcCtD
Thioridazine—Sweating increased—Imiquimod—skin cancer	0.0015	0.00976	CcSEcCtD
Thioridazine—HTR2A—nerve—skin cancer	0.00147	0.0258	CbGeAlD
Thioridazine—Pancytopenia—Imiquimod—skin cancer	0.00146	0.00952	CcSEcCtD
Thioridazine—Decreased appetite—Vismodegib—skin cancer	0.00144	0.0094	CcSEcCtD
Thioridazine—Oedema peripheral—Vemurafenib—skin cancer	0.00142	0.00926	CcSEcCtD
Thioridazine—Constipation—Vismodegib—skin cancer	0.00142	0.00925	CcSEcCtD
Thioridazine—Photosensitivity reaction—Imiquimod—skin cancer	0.0014	0.00915	CcSEcCtD
Thioridazine—Aplastic anaemia—Temozolomide—skin cancer	0.00138	0.00899	CcSEcCtD
Thioridazine—Dermatitis contact—Fluorouracil—skin cancer	0.00134	0.00872	CcSEcCtD
Thioridazine—HTR7—neck—skin cancer	0.00132	0.0232	CbGeAlD
Thioridazine—Hepatotoxicity—Docetaxel—skin cancer	0.00126	0.00824	CcSEcCtD
Thioridazine—Erythema—Vemurafenib—skin cancer	0.00125	0.00819	CcSEcCtD
Thioridazine—HTR2A—endothelium—skin cancer	0.00125	0.022	CbGeAlD
Thioridazine—KCNH2—nipple—skin cancer	0.00124	0.0219	CbGeAlD
Thioridazine—Lethargy—Dactinomycin—skin cancer	0.0012	0.00784	CcSEcCtD
Thioridazine—HTR6—head—skin cancer	0.0012	0.0211	CbGeAlD
Thioridazine—Nasal congestion—Temozolomide—skin cancer	0.00117	0.00763	CcSEcCtD
Thioridazine—HTR2A—blood vessel—skin cancer	0.00115	0.0203	CbGeAlD
Thioridazine—Diarrhoea—Vismodegib—skin cancer	0.00113	0.0074	CcSEcCtD
Thioridazine—Dermatitis exfoliative—Temozolomide—skin cancer	0.00113	0.00736	CcSEcCtD
Thioridazine—Photosensitivity—Fluorouracil—skin cancer	0.00112	0.00729	CcSEcCtD
Thioridazine—Amenorrhoea—Docetaxel—skin cancer	0.00111	0.00724	CcSEcCtD
Thioridazine—Arrhythmia—Imiquimod—skin cancer	0.0011	0.00717	CcSEcCtD
Thioridazine—Mental disorder—Imiquimod—skin cancer	0.00108	0.00703	CcSEcCtD
Thioridazine—Erythema—Imiquimod—skin cancer	0.00107	0.00698	CcSEcCtD
Thioridazine—CYP1A2—nipple—skin cancer	0.00107	0.0187	CbGeAlD
Thioridazine—Vomiting—Vismodegib—skin cancer	0.00105	0.00688	CcSEcCtD
Thioridazine—Rash—Vismodegib—skin cancer	0.00105	0.00682	CcSEcCtD
Thioridazine—Dermatitis—Vismodegib—skin cancer	0.00104	0.00681	CcSEcCtD
Thioridazine—Pancytopenia—Bleomycin—skin cancer	0.00104	0.00676	CcSEcCtD
Thioridazine—Lethargy—Fluorouracil—skin cancer	0.001	0.00653	CcSEcCtD
Thioridazine—HRH1—nipple—skin cancer	0.000997	0.0175	CbGeAlD
Thioridazine—Nausea—Vismodegib—skin cancer	0.000985	0.00642	CcSEcCtD
Thioridazine—Agitation—Imiquimod—skin cancer	0.000984	0.00642	CcSEcCtD
Thioridazine—ADRA2A—nipple—skin cancer	0.000979	0.0172	CbGeAlD
Thioridazine—Angioedema—Imiquimod—skin cancer	0.000978	0.00638	CcSEcCtD
Thioridazine—Pancytopenia—Dactinomycin—skin cancer	0.000966	0.00631	CcSEcCtD
Thioridazine—ADRA1B—head—skin cancer	0.000958	0.0169	CbGeAlD
Thioridazine—Hypotension—Vemurafenib—skin cancer	0.000957	0.00624	CcSEcCtD
Thioridazine—HTR7—connective tissue—skin cancer	0.000947	0.0167	CbGeAlD
Thioridazine—Cardiac arrest—Fluorouracil—skin cancer	0.000933	0.00609	CcSEcCtD
Thioridazine—HTR7—epithelium—skin cancer	0.000899	0.0158	CbGeAlD
Thioridazine—Sweating increased—Temozolomide—skin cancer	0.000897	0.00585	CcSEcCtD
Thioridazine—DRD1—head—skin cancer	0.000893	0.0157	CbGeAlD
Thioridazine—Decreased appetite—Vemurafenib—skin cancer	0.00089	0.00581	CcSEcCtD
Thioridazine—Constipation—Vemurafenib—skin cancer	0.000876	0.00571	CcSEcCtD
Thioridazine—Pancytopenia—Temozolomide—skin cancer	0.000874	0.0057	CcSEcCtD
Thioridazine—Oedema—Imiquimod—skin cancer	0.000873	0.0057	CcSEcCtD
Thioridazine—ADRA1A—epithelium—skin cancer	0.000867	0.0153	CbGeAlD
Thioridazine—Tachycardia—Imiquimod—skin cancer	0.000852	0.00556	CcSEcCtD
Thioridazine—Agranulocytosis—Dactinomycin—skin cancer	0.000847	0.00552	CcSEcCtD
Thioridazine—Hyperhidrosis—Imiquimod—skin cancer	0.000844	0.00551	CcSEcCtD
Thioridazine—Photosensitivity reaction—Temozolomide—skin cancer	0.00084	0.00548	CcSEcCtD
Thioridazine—Eosinophilia—Fluorouracil—skin cancer	0.00084	0.00548	CcSEcCtD
Thioridazine—Weight increased—Temozolomide—skin cancer	0.000838	0.00546	CcSEcCtD
Thioridazine—Anorexia—Imiquimod—skin cancer	0.000833	0.00543	CcSEcCtD
Thioridazine—HTR2C—female reproductive system—skin cancer	0.00083	0.0146	CbGeAlD
Thioridazine—HTR2A—neck—skin cancer	0.000824	0.0145	CbGeAlD
Thioridazine—Body temperature increased—Vemurafenib—skin cancer	0.00081	0.00528	CcSEcCtD
Thioridazine—Pancytopenia—Fluorouracil—skin cancer	0.000805	0.00525	CcSEcCtD
Thioridazine—Somnolence—Imiquimod—skin cancer	0.000777	0.00507	CcSEcCtD
Thioridazine—Photosensitivity reaction—Fluorouracil—skin cancer	0.000774	0.00505	CcSEcCtD
Thioridazine—Erythema—Bleomycin—skin cancer	0.00076	0.00496	CcSEcCtD
Thioridazine—Decreased appetite—Imiquimod—skin cancer	0.000759	0.00495	CcSEcCtD
Thioridazine—Hypersensitivity—Vemurafenib—skin cancer	0.000755	0.00492	CcSEcCtD
Thioridazine—Oedema peripheral—Temozolomide—skin cancer	0.000726	0.00473	CcSEcCtD
Thioridazine—Lethargy—Docetaxel—skin cancer	0.000723	0.00471	CcSEcCtD
Thioridazine—Feeling abnormal—Imiquimod—skin cancer	0.00072	0.0047	CcSEcCtD
Thioridazine—CHRM2—head—skin cancer	0.00072	0.0127	CbGeAlD
Thioridazine—Erythema—Dactinomycin—skin cancer	0.000709	0.00463	CcSEcCtD
Thioridazine—HRH1—connective tissue—skin cancer	0.000707	0.0124	CbGeAlD
Thioridazine—Agranulocytosis—Fluorouracil—skin cancer	0.000706	0.0046	CcSEcCtD
Thioridazine—Anaemia—Bleomycin—skin cancer	0.000703	0.00458	CcSEcCtD
Thioridazine—Diarrhoea—Vemurafenib—skin cancer	0.000701	0.00457	CcSEcCtD
Thioridazine—ADRA2A—connective tissue—skin cancer	0.000695	0.0122	CbGeAlD
Thioridazine—HTR2C—head—skin cancer	0.000694	0.0122	CbGeAlD
Thioridazine—Body temperature increased—Imiquimod—skin cancer	0.00069	0.0045	CcSEcCtD
Thioridazine—Leukopenia—Bleomycin—skin cancer	0.000681	0.00444	CcSEcCtD
Thioridazine—HRH1—epithelium—skin cancer	0.000671	0.0118	CbGeAlD
Thioridazine—ADRA1A—lymphoid tissue—skin cancer	0.000668	0.0118	CbGeAlD
Thioridazine—HTR7—female reproductive system—skin cancer	0.000668	0.0118	CbGeAlD
Thioridazine—Anaemia—Dactinomycin—skin cancer	0.000655	0.00428	CcSEcCtD
Thioridazine—Vomiting—Vemurafenib—skin cancer	0.000651	0.00425	CcSEcCtD
Thioridazine—Rash—Vemurafenib—skin cancer	0.000646	0.00421	CcSEcCtD
Thioridazine—Mental disorder—Temozolomide—skin cancer	0.000645	0.00421	CcSEcCtD
Thioridazine—Dermatitis—Vemurafenib—skin cancer	0.000645	0.00421	CcSEcCtD
Thioridazine—Hypersensitivity—Imiquimod—skin cancer	0.000644	0.0042	CcSEcCtD
Thioridazine—Headache—Vemurafenib—skin cancer	0.000642	0.00419	CcSEcCtD
Thioridazine—Erythema—Temozolomide—skin cancer	0.000641	0.00418	CcSEcCtD
Thioridazine—Leukopenia—Dactinomycin—skin cancer	0.000635	0.00414	CcSEcCtD
Thioridazine—Confusional state—Bleomycin—skin cancer	0.000626	0.00408	CcSEcCtD
Thioridazine—KCNH2—female reproductive system—skin cancer	0.000622	0.0109	CbGeAlD
Thioridazine—Oedema—Bleomycin—skin cancer	0.000621	0.00405	CcSEcCtD
Thioridazine—Nausea—Vemurafenib—skin cancer	0.000608	0.00397	CcSEcCtD
Thioridazine—Thrombocytopenia—Bleomycin—skin cancer	0.000608	0.00396	CcSEcCtD
Thioridazine—Arrhythmia—Fluorouracil—skin cancer	0.000606	0.00396	CcSEcCtD
Thioridazine—Vision blurred—Temozolomide—skin cancer	0.000604	0.00394	CcSEcCtD
Thioridazine—Tremor—Temozolomide—skin cancer	0.000601	0.00392	CcSEcCtD
Thioridazine—Diarrhoea—Imiquimod—skin cancer	0.000598	0.0039	CcSEcCtD
Thioridazine—Anaemia—Temozolomide—skin cancer	0.000593	0.00387	CcSEcCtD
Thioridazine—Anorexia—Bleomycin—skin cancer	0.000592	0.00386	CcSEcCtD
Thioridazine—Erythema—Fluorouracil—skin cancer	0.000591	0.00386	CcSEcCtD
Thioridazine—HTR2A—connective tissue—skin cancer	0.000591	0.0104	CbGeAlD
Thioridazine—Agitation—Temozolomide—skin cancer	0.000589	0.00385	CcSEcCtD
Thioridazine—Angioedema—Temozolomide—skin cancer	0.000586	0.00382	CcSEcCtD
Thioridazine—HTR1A—head—skin cancer	0.000584	0.0103	CbGeAlD
Thioridazine—HRH1—mammalian vulva—skin cancer	0.000582	0.0102	CbGeAlD
Thioridazine—Pancytopenia—Docetaxel—skin cancer	0.000581	0.00379	CcSEcCtD
Thioridazine—Hypotension—Bleomycin—skin cancer	0.00058	0.00378	CcSEcCtD
Thioridazine—Oedema—Dactinomycin—skin cancer	0.000579	0.00378	CcSEcCtD
Thioridazine—Leukopenia—Temozolomide—skin cancer	0.000574	0.00375	CcSEcCtD
Thioridazine—ADRA2A—mammalian vulva—skin cancer	0.000572	0.0101	CbGeAlD
Thioridazine—CYP2C8—female reproductive system—skin cancer	0.000569	0.01	CbGeAlD
Thioridazine—Thrombocytopenia—Dactinomycin—skin cancer	0.000567	0.0037	CcSEcCtD
Thioridazine—HTR2A—epithelium—skin cancer	0.000561	0.00986	CbGeAlD
Thioridazine—HTR7—head—skin cancer	0.000558	0.00982	CbGeAlD
Thioridazine—Weight increased—Docetaxel—skin cancer	0.000557	0.00363	CcSEcCtD
Thioridazine—Vision blurred—Fluorouracil—skin cancer	0.000557	0.00363	CcSEcCtD
Thioridazine—Vomiting—Imiquimod—skin cancer	0.000555	0.00362	CcSEcCtD
Thioridazine—Anorexia—Dactinomycin—skin cancer	0.000552	0.0036	CcSEcCtD
Thioridazine—Rash—Imiquimod—skin cancer	0.000551	0.00359	CcSEcCtD
Thioridazine—Dermatitis—Imiquimod—skin cancer	0.00055	0.00359	CcSEcCtD
Thioridazine—Headache—Imiquimod—skin cancer	0.000547	0.00357	CcSEcCtD
Thioridazine—Anaemia—Fluorouracil—skin cancer	0.000546	0.00356	CcSEcCtD
Thioridazine—Decreased appetite—Bleomycin—skin cancer	0.000539	0.00352	CcSEcCtD
Thioridazine—ADRA1A—head—skin cancer	0.000538	0.00947	CbGeAlD
Thioridazine—Jaundice—Docetaxel—skin cancer	0.000532	0.00347	CcSEcCtD
Thioridazine—Leukopenia—Fluorouracil—skin cancer	0.000529	0.00345	CcSEcCtD
Thioridazine—Confusional state—Temozolomide—skin cancer	0.000528	0.00344	CcSEcCtD
Thioridazine—DRD2—head—skin cancer	0.000528	0.00928	CbGeAlD
Thioridazine—Oedema—Temozolomide—skin cancer	0.000523	0.00341	CcSEcCtD
Thioridazine—KCNH2—head—skin cancer	0.00052	0.00915	CbGeAlD
Thioridazine—Nausea—Imiquimod—skin cancer	0.000519	0.00338	CcSEcCtD
Thioridazine—Thrombocytopenia—Temozolomide—skin cancer	0.000513	0.00334	CcSEcCtD
Thioridazine—Feeling abnormal—Bleomycin—skin cancer	0.000511	0.00334	CcSEcCtD
Thioridazine—Agranulocytosis—Docetaxel—skin cancer	0.000509	0.00332	CcSEcCtD
Thioridazine—Hyperhidrosis—Temozolomide—skin cancer	0.000506	0.0033	CcSEcCtD
Thioridazine—CYP2C9—female reproductive system—skin cancer	0.000506	0.0089	CbGeAlD
Thioridazine—Decreased appetite—Dactinomycin—skin cancer	0.000503	0.00328	CcSEcCtD
Thioridazine—Anorexia—Temozolomide—skin cancer	0.000499	0.00326	CcSEcCtD
Thioridazine—HRH1—female reproductive system—skin cancer	0.000499	0.00877	CbGeAlD
Thioridazine—CYP2E1—lymphoid tissue—skin cancer	0.000497	0.00874	CbGeAlD
Thioridazine—Body temperature increased—Bleomycin—skin cancer	0.000491	0.0032	CcSEcCtD
Thioridazine—ADRA2A—female reproductive system—skin cancer	0.00049	0.00862	CbGeAlD
Thioridazine—Confusional state—Fluorouracil—skin cancer	0.000486	0.00317	CcSEcCtD
Thioridazine—Oedema peripheral—Docetaxel—skin cancer	0.000483	0.00315	CcSEcCtD
Thioridazine—Oedema—Fluorouracil—skin cancer	0.000482	0.00315	CcSEcCtD
Thioridazine—CYP2E1—female reproductive system—skin cancer	0.000479	0.00843	CbGeAlD
Thioridazine—Feeling abnormal—Dactinomycin—skin cancer	0.000477	0.00311	CcSEcCtD
Thioridazine—Thrombocytopenia—Fluorouracil—skin cancer	0.000472	0.00308	CcSEcCtD
Thioridazine—Tachycardia—Fluorouracil—skin cancer	0.000471	0.00307	CcSEcCtD
Thioridazine—Somnolence—Temozolomide—skin cancer	0.000465	0.00304	CcSEcCtD
Thioridazine—Anorexia—Fluorouracil—skin cancer	0.00046	0.003	CcSEcCtD
Thioridazine—Body temperature increased—Dactinomycin—skin cancer	0.000458	0.00298	CcSEcCtD
Thioridazine—Hypersensitivity—Bleomycin—skin cancer	0.000457	0.00298	CcSEcCtD
Thioridazine—Decreased appetite—Temozolomide—skin cancer	0.000455	0.00297	CcSEcCtD
Thioridazine—Hypotension—Fluorouracil—skin cancer	0.000451	0.00294	CcSEcCtD
Thioridazine—Constipation—Temozolomide—skin cancer	0.000448	0.00292	CcSEcCtD
Thioridazine—Arrhythmia—Docetaxel—skin cancer	0.000438	0.00286	CcSEcCtD
Thioridazine—Feeling abnormal—Temozolomide—skin cancer	0.000431	0.00281	CcSEcCtD
Thioridazine—Mental disorder—Docetaxel—skin cancer	0.000429	0.0028	CcSEcCtD
Thioridazine—Somnolence—Fluorouracil—skin cancer	0.000429	0.0028	CcSEcCtD
Thioridazine—Erythema—Docetaxel—skin cancer	0.000427	0.00278	CcSEcCtD
Thioridazine—Hypersensitivity—Dactinomycin—skin cancer	0.000426	0.00278	CcSEcCtD
Thioridazine—Decreased appetite—Fluorouracil—skin cancer	0.000419	0.00274	CcSEcCtD
Thioridazine—HRH1—head—skin cancer	0.000417	0.00733	CbGeAlD
Thioridazine—HTR2A—female reproductive system—skin cancer	0.000417	0.00733	CbGeAlD
Thioridazine—Body temperature increased—Temozolomide—skin cancer	0.000414	0.0027	CcSEcCtD
Thioridazine—ADRA2A—head—skin cancer	0.000409	0.0072	CbGeAlD
Thioridazine—CYP2E1—head—skin cancer	0.0004	0.00704	CbGeAlD
Thioridazine—Feeling abnormal—Fluorouracil—skin cancer	0.000397	0.00259	CcSEcCtD
Thioridazine—Diarrhoea—Dactinomycin—skin cancer	0.000396	0.00258	CcSEcCtD
Thioridazine—Vomiting—Bleomycin—skin cancer	0.000395	0.00257	CcSEcCtD
Thioridazine—Anaemia—Docetaxel—skin cancer	0.000394	0.00257	CcSEcCtD
Thioridazine—Rash—Bleomycin—skin cancer	0.000391	0.00255	CcSEcCtD
Thioridazine—Dermatitis—Bleomycin—skin cancer	0.000391	0.00255	CcSEcCtD
Thioridazine—Hypersensitivity—Temozolomide—skin cancer	0.000386	0.00252	CcSEcCtD
Thioridazine—Leukopenia—Docetaxel—skin cancer	0.000382	0.00249	CcSEcCtD
Thioridazine—Body temperature increased—Fluorouracil—skin cancer	0.000381	0.00249	CcSEcCtD
Thioridazine—CYP2D6—female reproductive system—skin cancer	0.000379	0.00668	CbGeAlD
Thioridazine—Nausea—Bleomycin—skin cancer	0.000369	0.0024	CcSEcCtD
Thioridazine—Vomiting—Dactinomycin—skin cancer	0.000368	0.0024	CcSEcCtD
Thioridazine—Rash—Dactinomycin—skin cancer	0.000365	0.00238	CcSEcCtD
Thioridazine—KCNH2—lymph node—skin cancer	0.000364	0.0064	CbGeAlD
Thioridazine—Diarrhoea—Temozolomide—skin cancer	0.000358	0.00234	CcSEcCtD
Thioridazine—Hypersensitivity—Fluorouracil—skin cancer	0.000355	0.00232	CcSEcCtD
Thioridazine—Confusional state—Docetaxel—skin cancer	0.000351	0.00229	CcSEcCtD
Thioridazine—Oedema—Docetaxel—skin cancer	0.000348	0.00227	CcSEcCtD
Thioridazine—HTR2A—head—skin cancer	0.000348	0.00612	CbGeAlD
Thioridazine—Nausea—Dactinomycin—skin cancer	0.000344	0.00224	CcSEcCtD
Thioridazine—Thrombocytopenia—Docetaxel—skin cancer	0.000341	0.00222	CcSEcCtD
Thioridazine—Tachycardia—Docetaxel—skin cancer	0.00034	0.00222	CcSEcCtD
Thioridazine—Vomiting—Temozolomide—skin cancer	0.000333	0.00217	CcSEcCtD
Thioridazine—Anorexia—Docetaxel—skin cancer	0.000332	0.00216	CcSEcCtD
Thioridazine—Rash—Temozolomide—skin cancer	0.00033	0.00215	CcSEcCtD
Thioridazine—Diarrhoea—Fluorouracil—skin cancer	0.00033	0.00215	CcSEcCtD
Thioridazine—Dermatitis—Temozolomide—skin cancer	0.00033	0.00215	CcSEcCtD
Thioridazine—Headache—Temozolomide—skin cancer	0.000328	0.00214	CcSEcCtD
Thioridazine—Hypotension—Docetaxel—skin cancer	0.000325	0.00212	CcSEcCtD
Thioridazine—CYP2D6—head—skin cancer	0.000317	0.00558	CbGeAlD
Thioridazine—Nausea—Temozolomide—skin cancer	0.000311	0.00203	CcSEcCtD
Thioridazine—Somnolence—Docetaxel—skin cancer	0.000309	0.00202	CcSEcCtD
Thioridazine—Vomiting—Fluorouracil—skin cancer	0.000307	0.002	CcSEcCtD
Thioridazine—Rash—Fluorouracil—skin cancer	0.000304	0.00198	CcSEcCtD
Thioridazine—Dermatitis—Fluorouracil—skin cancer	0.000304	0.00198	CcSEcCtD
Thioridazine—Decreased appetite—Docetaxel—skin cancer	0.000303	0.00197	CcSEcCtD
Thioridazine—Headache—Fluorouracil—skin cancer	0.000302	0.00197	CcSEcCtD
Thioridazine—Constipation—Docetaxel—skin cancer	0.000298	0.00194	CcSEcCtD
Thioridazine—HRH1—lymph node—skin cancer	0.000292	0.00513	CbGeAlD
Thioridazine—Feeling abnormal—Docetaxel—skin cancer	0.000287	0.00187	CcSEcCtD
Thioridazine—ADRA2A—lymph node—skin cancer	0.000287	0.00504	CbGeAlD
Thioridazine—Nausea—Fluorouracil—skin cancer	0.000286	0.00187	CcSEcCtD
Thioridazine—Body temperature increased—Docetaxel—skin cancer	0.000275	0.0018	CcSEcCtD
Thioridazine—Hypersensitivity—Docetaxel—skin cancer	0.000256	0.00167	CcSEcCtD
Thioridazine—Diarrhoea—Docetaxel—skin cancer	0.000238	0.00155	CcSEcCtD
Thioridazine—Vomiting—Docetaxel—skin cancer	0.000221	0.00144	CcSEcCtD
Thioridazine—Rash—Docetaxel—skin cancer	0.000219	0.00143	CcSEcCtD
Thioridazine—Dermatitis—Docetaxel—skin cancer	0.000219	0.00143	CcSEcCtD
Thioridazine—Headache—Docetaxel—skin cancer	0.000218	0.00142	CcSEcCtD
Thioridazine—Nausea—Docetaxel—skin cancer	0.000207	0.00135	CcSEcCtD
Thioridazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—skin cancer	4.58e-06	0.000842	CbGpPWpGaD
Thioridazine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—skin cancer	4.58e-06	0.000842	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—SUFU—skin cancer	4.57e-06	0.00084	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—SUFU—skin cancer	4.5e-06	0.000826	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—SUFU—skin cancer	4.49e-06	0.000824	CbGpPWpGaD
Thioridazine—DRD2—Circadian rythm related genes—TP53—skin cancer	4.46e-06	0.00082	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PLIN2—skin cancer	4.44e-06	0.000815	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—SUFU—skin cancer	4.42e-06	0.000811	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—SUFU—skin cancer	4.4e-06	0.000809	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PLIN2—skin cancer	4.4e-06	0.000808	CbGpPWpGaD
Thioridazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—skin cancer	4.39e-06	0.000806	CbGpPWpGaD
Thioridazine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—skin cancer	4.38e-06	0.000805	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—MC1R—skin cancer	4.38e-06	0.000805	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—PTCH1—skin cancer	4.38e-06	0.000804	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—SMO—skin cancer	4.38e-06	0.000804	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—FOXO4—skin cancer	4.37e-06	0.000803	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—FOXO4—skin cancer	4.37e-06	0.000802	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—CSPG4—skin cancer	4.36e-06	0.000801	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—GLI1—skin cancer	4.32e-06	0.000793	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—PTGER4—skin cancer	4.26e-06	0.000783	CbGpPWpGaD
Thioridazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—skin cancer	4.2e-06	0.000771	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—SUFU—skin cancer	4.09e-06	0.000752	CbGpPWpGaD
Thioridazine—DRD2—Circadian rythm related genes—IL6—skin cancer	4.08e-06	0.00075	CbGpPWpGaD
Thioridazine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—skin cancer	3.98e-06	0.000731	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—SHH—skin cancer	3.97e-06	0.000729	CbGpPWpGaD
Thioridazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—skin cancer	3.97e-06	0.000729	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—SHH—skin cancer	3.95e-06	0.000726	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—RASA1—skin cancer	3.95e-06	0.000725	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—RASA1—skin cancer	3.93e-06	0.000721	CbGpPWpGaD
Thioridazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—skin cancer	3.9e-06	0.000716	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—CSPG4—skin cancer	3.89e-06	0.000715	CbGpPWpGaD
Thioridazine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—skin cancer	3.81e-06	0.000699	CbGpPWpGaD
Thioridazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—skin cancer	3.8e-06	0.000698	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—SHH—skin cancer	3.78e-06	0.000695	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—PTCH1—skin cancer	3.76e-06	0.000691	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—FOXO4—skin cancer	3.76e-06	0.000691	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—SMO—skin cancer	3.76e-06	0.000691	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PLIN2—skin cancer	3.76e-06	0.000691	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—RASA1—skin cancer	3.76e-06	0.00069	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—SMO—skin cancer	3.74e-06	0.000688	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—PTCH1—skin cancer	3.74e-06	0.000688	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—ENO2—skin cancer	3.73e-06	0.000686	CbGpPWpGaD
Thioridazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—skin cancer	3.73e-06	0.000685	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—PTGER4—skin cancer	3.66e-06	0.000673	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—PTGER4—skin cancer	3.65e-06	0.00067	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—SMO—skin cancer	3.58e-06	0.000659	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—PTCH1—skin cancer	3.58e-06	0.000659	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—CSPG4—skin cancer	3.58e-06	0.000657	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—CSPG4—skin cancer	3.55e-06	0.000652	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—PTGER4—skin cancer	3.49e-06	0.000641	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—SHH—skin cancer	3.49e-06	0.00064	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—RASA1—skin cancer	3.46e-06	0.000636	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—SHH—skin cancer	3.43e-06	0.00063	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—ENO2—skin cancer	3.43e-06	0.00063	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—SHH—skin cancer	3.42e-06	0.000629	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—RASA1—skin cancer	3.41e-06	0.000626	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—RASA1—skin cancer	3.4e-06	0.000625	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—SHH—skin cancer	3.37e-06	0.000619	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—SHH—skin cancer	3.36e-06	0.000617	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—RASA1—skin cancer	3.35e-06	0.000615	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—RASA1—skin cancer	3.34e-06	0.000613	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—SMO—skin cancer	3.31e-06	0.000607	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—PTCH1—skin cancer	3.31e-06	0.000607	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—PTCH1—skin cancer	3.25e-06	0.000597	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—SMO—skin cancer	3.25e-06	0.000597	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—SMO—skin cancer	3.25e-06	0.000596	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—PTCH1—skin cancer	3.25e-06	0.000596	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—FOXO4—skin cancer	3.24e-06	0.000595	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—FOXO4—skin cancer	3.22e-06	0.000592	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—PTGER4—skin cancer	3.22e-06	0.000591	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—PTCH1—skin cancer	3.19e-06	0.000587	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—SMO—skin cancer	3.19e-06	0.000587	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—PTCH1—skin cancer	3.18e-06	0.000585	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—SMO—skin cancer	3.18e-06	0.000585	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—PTGER4—skin cancer	3.17e-06	0.000582	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—PTGER4—skin cancer	3.16e-06	0.00058	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—SHH—skin cancer	3.12e-06	0.000573	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—PTGER4—skin cancer	3.11e-06	0.000571	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—RASA1—skin cancer	3.1e-06	0.00057	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—PTGER4—skin cancer	3.1e-06	0.000569	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—FOXO4—skin cancer	3.08e-06	0.000566	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—CSPG4—skin cancer	3.03e-06	0.000557	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—ENO2—skin cancer	2.96e-06	0.000544	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—PTCH1—skin cancer	2.96e-06	0.000543	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—SMO—skin cancer	2.96e-06	0.000543	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—TERT—skin cancer	2.92e-06	0.000537	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—TERT—skin cancer	2.92e-06	0.000536	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—PTGER4—skin cancer	2.88e-06	0.000529	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—FOXO4—skin cancer	2.84e-06	0.000522	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—FOXO4—skin cancer	2.8e-06	0.000514	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—FOXO4—skin cancer	2.79e-06	0.000513	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—FOXO4—skin cancer	2.75e-06	0.000504	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—FOXO4—skin cancer	2.74e-06	0.000503	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—ENO2—skin cancer	2.64e-06	0.000486	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—FOXO4—skin cancer	2.54e-06	0.000467	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—TERT—skin cancer	2.51e-06	0.000462	CbGpPWpGaD
Thioridazine—ADRA2A—Hemostasis—NRAS—skin cancer	2.49e-06	0.000458	CbGpPWpGaD
Thioridazine—HTR6—Signaling by GPCR—NRAS—skin cancer	2.46e-06	0.000452	CbGpPWpGaD
Thioridazine—HTR7—Signaling by GPCR—NRAS—skin cancer	2.46e-06	0.000452	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—ENO2—skin cancer	2.43e-06	0.000447	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—ENO2—skin cancer	2.41e-06	0.000443	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	2.32e-06	0.000426	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—BRAF—skin cancer	2.31e-06	0.000425	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—BRAF—skin cancer	2.31e-06	0.000424	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—ERCC2—skin cancer	2.17e-06	0.000398	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—TERT—skin cancer	2.16e-06	0.000397	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—TERT—skin cancer	2.15e-06	0.000395	CbGpPWpGaD
Thioridazine—ADRA2A—Hemostasis—KRAS—skin cancer	2.15e-06	0.000394	CbGpPWpGaD
Thioridazine—DRD1—Signaling by GPCR—NRAS—skin cancer	2.12e-06	0.000389	CbGpPWpGaD
Thioridazine—HTR6—Signaling by GPCR—KRAS—skin cancer	2.12e-06	0.000389	CbGpPWpGaD
Thioridazine—HTR7—Signaling by GPCR—KRAS—skin cancer	2.12e-06	0.000389	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	2.07e-06	0.00038	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—ENO2—skin cancer	2.06e-06	0.000378	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—TERT—skin cancer	2.06e-06	0.000378	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—BRAF—skin cancer	1.99e-06	0.000366	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—ERCC2—skin cancer	1.99e-06	0.000366	CbGpPWpGaD
Thioridazine—ADRA2A—Hemostasis—TP53—skin cancer	1.91e-06	0.000351	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—TERT—skin cancer	1.9e-06	0.000349	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.89e-06	0.000346	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—TERT—skin cancer	1.87e-06	0.000343	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—TERT—skin cancer	1.86e-06	0.000342	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—TERT—skin cancer	1.83e-06	0.000337	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—TERT—skin cancer	1.83e-06	0.000336	CbGpPWpGaD
Thioridazine—ADRA2A—Hemostasis—HRAS—skin cancer	1.83e-06	0.000335	CbGpPWpGaD
Thioridazine—DRD1—Signaling by GPCR—KRAS—skin cancer	1.82e-06	0.000335	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—NRAS—skin cancer	1.82e-06	0.000335	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—NRAS—skin cancer	1.81e-06	0.000333	CbGpPWpGaD
Thioridazine—HTR6—Signaling by GPCR—HRAS—skin cancer	1.8e-06	0.000331	CbGpPWpGaD
Thioridazine—HTR7—Signaling by GPCR—HRAS—skin cancer	1.8e-06	0.00033	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—NRAS—skin cancer	1.73e-06	0.000319	CbGpPWpGaD
Thioridazine—HTR6—Signaling by GPCR—IL6—skin cancer	1.72e-06	0.000317	CbGpPWpGaD
Thioridazine—HTR7—Signaling by GPCR—IL6—skin cancer	1.72e-06	0.000316	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—ERCC2—skin cancer	1.72e-06	0.000316	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—BRAF—skin cancer	1.71e-06	0.000315	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—BRAF—skin cancer	1.7e-06	0.000313	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—TERT—skin cancer	1.7e-06	0.000312	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—BRAF—skin cancer	1.63e-06	0.0003	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.61e-06	0.000296	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—NRAS—skin cancer	1.6e-06	0.000294	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—NRAS—skin cancer	1.57e-06	0.000289	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—NRAS—skin cancer	1.57e-06	0.000288	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—KRAS—skin cancer	1.57e-06	0.000288	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—KRAS—skin cancer	1.56e-06	0.000287	CbGpPWpGaD
Thioridazine—DRD1—Signaling by GPCR—HRAS—skin cancer	1.55e-06	0.000285	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—NRAS—skin cancer	1.55e-06	0.000284	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—NRAS—skin cancer	1.54e-06	0.000283	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—ERCC2—skin cancer	1.54e-06	0.000282	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—BRAF—skin cancer	1.5e-06	0.000276	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—KRAS—skin cancer	1.49e-06	0.000274	CbGpPWpGaD
Thioridazine—DRD1—Signaling by GPCR—IL6—skin cancer	1.48e-06	0.000272	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—BRAF—skin cancer	1.48e-06	0.000272	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—BRAF—skin cancer	1.48e-06	0.000271	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—NRAS—skin cancer	1.45e-06	0.000267	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—BRAF—skin cancer	1.45e-06	0.000267	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—NRAS—skin cancer	1.45e-06	0.000267	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—BRAF—skin cancer	1.45e-06	0.000266	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—NRAS—skin cancer	1.43e-06	0.000263	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—ERCC2—skin cancer	1.41e-06	0.00026	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—ERCC2—skin cancer	1.4e-06	0.000257	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—KRAS—skin cancer	1.38e-06	0.000253	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—KRAS—skin cancer	1.35e-06	0.000249	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—KRAS—skin cancer	1.35e-06	0.000248	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—BRAF—skin cancer	1.35e-06	0.000247	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—HRAS—skin cancer	1.33e-06	0.000245	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—KRAS—skin cancer	1.33e-06	0.000244	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—KRAS—skin cancer	1.33e-06	0.000244	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—HRAS—skin cancer	1.33e-06	0.000244	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—PTGS2—skin cancer	1.3e-06	0.000239	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—IL6—skin cancer	1.28e-06	0.000234	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—HRAS—skin cancer	1.27e-06	0.000233	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—IL6—skin cancer	1.27e-06	0.000233	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—NRAS—skin cancer	1.25e-06	0.00023	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—KRAS—skin cancer	1.25e-06	0.00023	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—KRAS—skin cancer	1.25e-06	0.00023	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—KRAS—skin cancer	1.23e-06	0.000226	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—IL6—skin cancer	1.21e-06	0.000223	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—ERCC2—skin cancer	1.2e-06	0.00022	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—PTGS2—skin cancer	1.19e-06	0.000219	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—HRAS—skin cancer	1.17e-06	0.000215	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—HRAS—skin cancer	1.15e-06	0.000211	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—HRAS—skin cancer	1.15e-06	0.000211	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—HRAS—skin cancer	1.13e-06	0.000208	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—HRAS—skin cancer	1.13e-06	0.000207	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—IL6—skin cancer	1.12e-06	0.000206	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—TP53—skin cancer	1.11e-06	0.000204	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—TP53—skin cancer	1.11e-06	0.000204	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—IL6—skin cancer	1.1e-06	0.000202	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—IL6—skin cancer	1.1e-06	0.000202	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—IL6—skin cancer	1.08e-06	0.000199	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—IL6—skin cancer	1.08e-06	0.000198	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—KRAS—skin cancer	1.08e-06	0.000198	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—NRAS—skin cancer	1.08e-06	0.000198	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—NRAS—skin cancer	1.07e-06	0.000197	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—HRAS—skin cancer	1.06e-06	0.000195	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—HRAS—skin cancer	1.06e-06	0.000195	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—HRAS—skin cancer	1.05e-06	0.000192	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—PTGS2—skin cancer	1.03e-06	0.00019	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—NRAS—skin cancer	1.02e-06	0.000188	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—IL6—skin cancer	1.02e-06	0.000187	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—IL6—skin cancer	1.02e-06	0.000187	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—IL6—skin cancer	1e-06	0.000184	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—TP53—skin cancer	9.57e-07	0.000176	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—NRAS—skin cancer	9.45e-07	0.000174	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—NRAS—skin cancer	9.3e-07	0.000171	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—NRAS—skin cancer	9.28e-07	0.00017	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—KRAS—skin cancer	9.26e-07	0.00017	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—KRAS—skin cancer	9.21e-07	0.000169	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—PTGS2—skin cancer	9.21e-07	0.000169	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—HRAS—skin cancer	9.15e-07	0.000168	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—NRAS—skin cancer	9.13e-07	0.000168	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—NRAS—skin cancer	9.1e-07	0.000167	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—KRAS—skin cancer	8.82e-07	0.000162	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—IL6—skin cancer	8.76e-07	0.000161	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PTGS2—skin cancer	8.47e-07	0.000156	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—NRAS—skin cancer	8.46e-07	0.000155	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PTGS2—skin cancer	8.4e-07	0.000154	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—TP53—skin cancer	8.23e-07	0.000151	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—TP53—skin cancer	8.19e-07	0.00015	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—KRAS—skin cancer	8.13e-07	0.000149	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—KRAS—skin cancer	8e-07	0.000147	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—KRAS—skin cancer	7.98e-07	0.000147	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—HRAS—skin cancer	7.87e-07	0.000145	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—KRAS—skin cancer	7.86e-07	0.000144	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—TP53—skin cancer	7.84e-07	0.000144	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—KRAS—skin cancer	7.83e-07	0.000144	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—HRAS—skin cancer	7.83e-07	0.000144	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—IL6—skin cancer	7.53e-07	0.000138	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—HRAS—skin cancer	7.5e-07	0.000138	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—IL6—skin cancer	7.5e-07	0.000138	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—KRAS—skin cancer	7.28e-07	0.000134	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—TP53—skin cancer	7.23e-07	0.000133	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PTGS2—skin cancer	7.18e-07	0.000132	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—IL6—skin cancer	7.18e-07	0.000132	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—TP53—skin cancer	7.11e-07	0.000131	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—TP53—skin cancer	7.1e-07	0.00013	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—TP53—skin cancer	6.98e-07	0.000128	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—TP53—skin cancer	6.96e-07	0.000128	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—HRAS—skin cancer	6.91e-07	0.000127	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—HRAS—skin cancer	6.8e-07	0.000125	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—HRAS—skin cancer	6.79e-07	0.000125	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—HRAS—skin cancer	6.68e-07	0.000123	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—HRAS—skin cancer	6.66e-07	0.000122	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—IL6—skin cancer	6.62e-07	0.000122	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—IL6—skin cancer	6.51e-07	0.00012	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—IL6—skin cancer	6.5e-07	0.000119	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—TP53—skin cancer	6.47e-07	0.000119	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—IL6—skin cancer	6.39e-07	0.000117	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—IL6—skin cancer	6.37e-07	0.000117	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—HRAS—skin cancer	6.19e-07	0.000114	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—IL6—skin cancer	5.92e-07	0.000109	CbGpPWpGaD
